dopamine: be prefered over adrenaline in cardiogenic shock

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents neurotransmitter
Weight: 0.73
, chemical
Weight: 0.69
, hormone
Weight: 0.68
, neuron
Weight: 0.67
, drug
Weight: 0.67
Siblings acetylcholine
Weight: 0.41
, serotonin
Weight: 0.41
, vasopressin
Weight: 0.39
, oxytocin
Weight: 0.39
, norepinephrine
Weight: 0.38

Related properties

Property Similarity
be prefered over adrenaline in cardiogenic shock 1.00
be prefered over adrenaline in shock 0.97
be prefered over adrenaline 0.93
be preferred over adrenaline 0.90
be used in cardiogenic shock 0.86
be used in shock 0.81
be given for shock 0.80
be given for cardiovascular shock 0.78
be contraindicated in hypovolemic shock 0.77
be contraindicated in shock 0.76

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.08
Rule weight: 0.13
Evidence weight: 0.78
Similarity weight: 0.80
Evidence: 0.59
¬ Remarkable(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.37
¬ Remarkable(norepinephrine, be given for shock)
0.06
Rule weight: 0.13
Evidence weight: 0.52
Similarity weight: 0.81
Evidence: 0.59
¬ Remarkable(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.82
¬ Remarkable(vasopressin, be used in shock)

Remarkability from sibling implausibility

0.48
Rule weight: 0.60
Evidence weight: 0.98
Similarity weight: 0.81
Evidence: 0.85
Plausible(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.82
Remarkable(vasopressin, be used in shock)
Evidence: 0.94
¬ Plausible(vasopressin, be used in shock)
0.44
Rule weight: 0.60
Evidence weight: 0.91
Similarity weight: 0.80
Evidence: 0.85
Plausible(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.37
Remarkable(norepinephrine, be given for shock)
Evidence: 0.99
¬ Plausible(norepinephrine, be given for shock)

Salient implies Plausible

0.24
Rule weight: 0.28
Evidence weight: 0.87
Similarity weight: 1.00
Evidence: 0.85
Plausible(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.90
¬ Salient(dopamine, be prefered over adrenaline in cardiogenic shock)

Similarity expansion

0.77
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.97
Evidence: 0.90
Salient(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.79
¬ Salient(dopamine, be prefered over adrenaline in shock)
0.76
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.97
Evidence: 0.90
Typical(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.86
¬ Typical(dopamine, be prefered over adrenaline in shock)
0.74
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.93
Evidence: 0.90
Salient(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.67
¬ Salient(dopamine, be prefered over adrenaline)
0.74
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.93
Evidence: 0.90
Typical(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.69
¬ Typical(dopamine, be prefered over adrenaline)
0.74
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.97
Evidence: 0.85
Plausible(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.78
¬ Plausible(dopamine, be prefered over adrenaline in shock)
0.72
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.86
Evidence: 0.90
Typical(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.23
¬ Typical(dopamine, be used in cardiogenic shock)
0.72
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.90
Evidence: 0.90
Salient(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.62
¬ Salient(dopamine, be preferred over adrenaline)
0.71
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.90
Evidence: 0.90
Typical(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.65
¬ Typical(dopamine, be preferred over adrenaline)
0.70
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.86
Evidence: 0.90
Salient(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.58
¬ Salient(dopamine, be used in cardiogenic shock)
0.70
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.86
Evidence: 0.85
Plausible(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.39
¬ Plausible(dopamine, be used in cardiogenic shock)
0.69
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.93
Evidence: 0.85
Plausible(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.95
¬ Plausible(dopamine, be prefered over adrenaline)
0.67
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.97
Evidence: 0.59
Remarkable(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.48
¬ Remarkable(dopamine, be prefered over adrenaline in shock)
0.66
Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.81
Evidence: 0.90
Typical(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.39
¬ Typical(dopamine, be used in shock)
0.66
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.90
Evidence: 0.85
Plausible(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.94
¬ Plausible(dopamine, be preferred over adrenaline)
0.65
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.93
Evidence: 0.59
Remarkable(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.44
¬ Remarkable(dopamine, be prefered over adrenaline)
0.65
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.81
Evidence: 0.90
Salient(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.64
¬ Salient(dopamine, be used in shock)
0.65
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.80
Evidence: 0.90
Salient(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.54
¬ Salient(dopamine, be given for shock)
0.65
Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.78
Evidence: 0.90
Salient(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.34
¬ Salient(dopamine, be given for cardiovascular shock)
0.63
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.90
Evidence: 0.59
Remarkable(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.42
¬ Remarkable(dopamine, be preferred over adrenaline)
0.63
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.80
Evidence: 0.90
Typical(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.68
¬ Typical(dopamine, be given for shock)
0.63
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.78
Evidence: 0.90
Typical(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.55
¬ Typical(dopamine, be given for cardiovascular shock)
0.63
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.78
Evidence: 0.85
Plausible(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.41
¬ Plausible(dopamine, be given for cardiovascular shock)
0.62
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.77
Evidence: 0.90
Typical(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.55
¬ Typical(dopamine, be contraindicated in hypovolemic shock)
0.61
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.76
Evidence: 0.90
Typical(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.52
¬ Typical(dopamine, be contraindicated in shock)
0.61
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.77
Evidence: 0.90
Salient(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.75
¬ Salient(dopamine, be contraindicated in hypovolemic shock)
0.60
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.81
Evidence: 0.85
Plausible(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.88
¬ Plausible(dopamine, be used in shock)
0.60
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.76
Evidence: 0.90
Salient(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.73
¬ Salient(dopamine, be contraindicated in shock)
0.60
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.77
Evidence: 0.85
Plausible(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.60
¬ Plausible(dopamine, be contraindicated in hypovolemic shock)
0.59
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.76
Evidence: 0.85
Plausible(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.58
¬ Plausible(dopamine, be contraindicated in shock)
0.59
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.80
Evidence: 0.85
Plausible(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.93
¬ Plausible(dopamine, be given for shock)
0.59
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.80
Evidence: 0.59
Remarkable(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.34
¬ Remarkable(dopamine, be given for shock)
0.58
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.78
Evidence: 0.59
Remarkable(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.33
¬ Remarkable(dopamine, be given for cardiovascular shock)
0.48
Rule weight: 0.85
Evidence weight: 0.70
Similarity weight: 0.81
Evidence: 0.59
Remarkable(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.73
¬ Remarkable(dopamine, be used in shock)
0.48
Rule weight: 0.85
Evidence weight: 0.65
Similarity weight: 0.86
Evidence: 0.59
Remarkable(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.86
¬ Remarkable(dopamine, be used in cardiogenic shock)
0.45
Rule weight: 0.85
Evidence weight: 0.68
Similarity weight: 0.77
Evidence: 0.59
Remarkable(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.78
¬ Remarkable(dopamine, be contraindicated in hypovolemic shock)
0.44
Rule weight: 0.85
Evidence weight: 0.68
Similarity weight: 0.76
Evidence: 0.59
Remarkable(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.79
¬ Remarkable(dopamine, be contraindicated in shock)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.95
Similarity weight: 1.00
Evidence: 0.90
Salient(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.90
¬ Typical(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.59
¬ Remarkable(dopamine, be prefered over adrenaline in cardiogenic shock)

Typical implies Plausible

0.42
Rule weight: 0.48
Evidence weight: 0.87
Similarity weight: 1.00
Evidence: 0.85
Plausible(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.90
¬ Typical(dopamine, be prefered over adrenaline in cardiogenic shock)

Typicality and Rermarkability incompatibility between siblings

0.08
Rule weight: 0.14
Evidence weight: 0.73
Similarity weight: 0.81
Evidence: 0.59
¬ Remarkable(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.46
¬ Typical(vasopressin, be used in shock)
0.05
Rule weight: 0.14
Evidence weight: 0.45
Similarity weight: 0.80
Evidence: 0.59
¬ Remarkable(dopamine, be prefered over adrenaline in cardiogenic shock)
Evidence: 0.93
¬ Typical(norepinephrine, be given for shock)